Insiders · Profile

Keutzer Timothy

Chief Operating Officer at Spero Therapeutics. Filing since 2 Feb 2023. CIK 0001798155

Company

Date

Role

Action

Shares

Amount

Of holding

SPRO Spero Therapeutics, Inc.

6 Feb 2026

Chief Operating Officer

Sold at will

18,652

$44.02K

2.5%

SPRO Spero Therapeutics, Inc.

4 Feb 2026

Chief Operating Officer

Sold at will

3,471

$7.78K

0.5%

SPRO Spero Therapeutics, Inc.

3 Feb 2026

Chief Operating Officer

Sold at will

24,224

$51.84K

3.1%

SPRO Spero Therapeutics, Inc.

2 Feb 2026

Chief Operating Officer

Sold at will

18,891

$41.56K

2.3%

SPRO Spero Therapeutics, Inc.

28 Aug 2025

Chief Operating Officer

Sold at will

1,695

$3.34K

0.2%

SPRO Spero Therapeutics, Inc.

5 Feb 2025

Chief Operating Officer

Sold at will

56,537

$44.10K

7.1%

SPRO Spero Therapeutics, Inc.

27 Aug 2024

Chief Operating Officer

Sold at will

2,213

$2.99K

0.4%

SPRO Spero Therapeutics, Inc.

2 Feb 2024

Chief Operating Officer

Sold at will

30,971

$42.12K

5.5%

SPRO Spero Therapeutics, Inc.

28 Aug 2023

Chief Development Officer

Sold at will

1,854

$2.34K

0.6%

SPRO Spero Therapeutics, Inc.

2 Feb 2023

Chief Operating Officer

Sold, plan not stated

3,394

$6.31K

1.0%

10 decisions on file.